Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

MEASURING DEVELOPER PRODUCTIVITY: REAL-WORLD EXAMPLES

Tech companies like Google and LinkedIn measure developer productivity in different ways. Common metrics in the industry that are commonly tracked as proxies for productivity are ease of delivery, experiment velocity, and the stability of services and apps. However, quantitative metrics alone can’t describe the full picture. Teams should start with defining specific goals and problems first, then pick the right quantitative and qualitative metrics for those goals.

PROSHARES FILES FOR FIVE LEVERAGED AND INVERSE BITCOIN ETFS

ProShares has submitted proposals for five leveraged and inverse Bitcoin ETFs. This comes on the heels of the SEC's approval of 11 spot Bitcoin ETFs. The five proposed funds are named ProShares Plus Bitcoin ETF, ProShares Ultra Bitcoin ETF, ProShares UltraShort Bitcoin ETF, ProShares Short Bitcoin ETF, and ProShares ShortPlus Bitcoin ETF. The spot Bitcoin ETFs are off to a fast start, with billions of dollars in trading volume in the first few days, so these proposed ETFs are presumably aiming to capitalize on that, giving investors more ways to get exposure to Bitcoin, either by shorting it or being able to leverage long it.

OPENAI CHANGES ITS STANCE, ANNOUNCES THAT IT IS WORKING WITH THE PENTAGON

OpenAI has announced a partnership with the Pentagon. The company's usage policy previously banned activities like weapons development and military use and warfare, but it recently updated its policies to remove the part about military use and warfare. OpenAI and the Pentagon are working on cybersecurity software and are in discussions about how OpenAI's technology could assist with preventing veteran suicide.

EXPERIMENTAL ULTRASOUND TREATMENT TARGETING BRAINS IN TRIALS TO HELP THOSE WITH ALZHEIMER'S, DRUG ADDICTION

A new experimental treatment uses ultrasound to open the blood-brain barrier using a specialized helmet to temporarily allow therapeutic drugs to quickly get inside the brain. Patients are awake during the procedure but they say the procedure is painless. In human trials, the treatment resulted in a clear reduction in the beta-amyloid proteins targeted. The treatment has also shown efficacy in treating patients with severe drug addictions.

A CLONED RHESUS MONKEY IS STILL ALIVE AFTER 2 YEARS

A team of researchers at the Chinese Academy of Sciences claims one of its cloned monkeys has lived more than two years, the longest any cloned rhesus macaque has survived yet. It was developed using a new method called the trophoblast replacement method. The new technique could have implications for conventional IVF. There is still a lot of trial and error involved - the researchers achieved just one live fetus for every 113 activated embryos, and of all 11 embryos transferred to a womb, only one produced a live fetus.

TLDR IndexPage 1